OncoTEX
Company

OncoTEX

Biotechnology Research Austin, Texas, United States 4 employees
Employees
4

OncoTEX Overview

Headquarters
Austin, Texas, United States
Industry
Biotechnology Research
Employees
4
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About OncoTEX

OncoTEX is developing TEX Core, a world-first oncology drug platform designed to create innovative therapies capable of overcoming multiple limitations often associated with current cancer therapeutics, including the predominant platinum-based resistance. OxaliTEX is the first clinical candidate developed from the TEX Core platform for the treatment of platinum-resistant ovarian cancer. TEX Core is designed to target tumor cells by overcoming challenges associated with the current platinum-based standards-of-care (SOC).

OncoTEX Contact Details

People in AeroLeads
2

OncoTEX Org Chart

Sample employees and titles
Name Title Contact
Corey Meek Data Entry Clerk at Oncotex
View
Jeff Heffelfinger, Fache Healthcare Executive with Expertise
View

Compare Similar Companies to OncoTEX